Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits.
Etienne I, Toupance O, Bénichou J, Thierry A, Al Najjar A, Hurault de Ligny B, Le Meur Y, Westeel PF, Marquet P, François A, Hellot MF, Godin M. Etienne I, et al. Among authors: hurault de ligny b. Nephrol Dial Transplant. 2010 Sep;25(9):3096-106. doi: 10.1093/ndt/gfq135. Epub 2010 Mar 17. Nephrol Dial Transplant. 2010. PMID: 20299336 Clinical Trial.
Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids.
Büchler M, Caillard S, Barbier S, Thervet E, Toupance O, Mazouz H, Hurault de Ligny B, Le Meur Y, Thierry A, Villemain F, Heng AE, Moulin B, Morin MP, Noël C, Lebranchu Y; SPIESSER Group. Büchler M, et al. Among authors: hurault de ligny b. Am J Transplant. 2007 Nov;7(11):2522-31. doi: 10.1111/j.1600-6143.2007.01976.x. Epub 2007 Sep 14. Am J Transplant. 2007. PMID: 17868057 Free article. Clinical Trial.
Progression of pulse pressure in kidney recipients durably exposed to CsA is a risk factor for epithelial phenotypic changes: an ancillary study of the CONCEPT trial.
Xu-Dubois YC, Hertig A, Lebranchu Y, Hurault de Ligny B, Thervet E, Jauréguy M, Touchard G, Le Pogamp P, Le Meur Y, Toupance O, Heng AE, Bayle F, Girardot-Seguin S, Servais A, Meas-Yedid V, Rondeau E. Xu-Dubois YC, et al. Among authors: hurault de ligny b. Transpl Int. 2014 Apr;27(4):344-52. doi: 10.1111/tri.12253. Epub 2014 Jan 28. Transpl Int. 2014. PMID: 24279707 Free article. Clinical Trial.
Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation.
Gatault P, Bertrand D, Büchler M, Colosio C, Hurault de Ligny B, Weestel PF, Rerolle JP, Thierry A, Sayegh J, Moulin B, Snanoudj R, Rivalan J, Heng AE, Sautenet B, Lebranchu Y. Gatault P, et al. Among authors: hurault de ligny b. Transpl Int. 2016 Jan;29(1):41-50. doi: 10.1111/tri.12656. Transpl Int. 2016. PMID: 26285161 Free article. Clinical Trial.
Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
Thierry A, Le Meur Y, Ecotière L, Abou-Ayache R, Etienne I, Laurent C, Vuiblet V, Colosio C, Bouvier N, Aldigier JC, Rerolle JP, Javaugue V, Gand E, Bridoux F, Essig M, Hurault de Ligny B, Touchard G. Thierry A, et al. Among authors: hurault de ligny b. Transpl Int. 2016 Jan;29(1):23-33. doi: 10.1111/tri.12627. Transpl Int. 2016. PMID: 26729582 Free article. Clinical Trial.
Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.
Lebranchu Y, Bridoux F, Büchler M, Le Meur Y, Etienne I, Toupance O, Hurault de Ligny B, Touchard G, Moulin B, Le Pogamp P, Reigneau O, Guignard M, Rifle G. Lebranchu Y, et al. Among authors: hurault de ligny b. Am J Transplant. 2002 Jan;2(1):48-56. doi: 10.1034/j.1600-6143.2002.020109.x. Am J Transplant. 2002. PMID: 12095056 Free article. Clinical Trial.
Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study.
Lebranchu Y, Thierry A, Toupance O, Westeel PF, Etienne I, Thervet E, Moulin B, Frouget T, Le Meur Y, Glotz D, Heng AE, Onno C, Buchler M, Girardot-Seguin S, Hurault de Ligny B. Lebranchu Y, et al. Among authors: hurault de ligny b. Am J Transplant. 2009 May;9(5):1115-23. doi: 10.1111/j.1600-6143.2009.02615.x. Am J Transplant. 2009. PMID: 19422337 Free article. Clinical Trial.
Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the Postconcept study.
Lebranchu Y, Thierry A, Thervet E, Büchler M, Etienne I, Westeel PF, Hurault de Ligny B, Moulin B, Rérolle JP, Frouget T, Girardot-Seguin S, Toupance O. Lebranchu Y, et al. Among authors: hurault de ligny b. Am J Transplant. 2011 Aug;11(8):1665-75. doi: 10.1111/j.1600-6143.2011.03637.x. Am J Transplant. 2011. PMID: 21797975 Free article. Clinical Trial.
203 results